Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis
Research output: Contribution to journal › Case report › Contributed › peer-review
Contributors
Abstract
BACKGROUND: There are only a few reports of pulmonary hypertension (PH) in hypersensitivity pneumonitis (HP) and an approved vasomodulatory therapy for PH does not exist at all for interstitial lung disease (ILD), particularly for HP.
CASE REPORT: The case of a 53-year-old woman with chronic HP and severe life-threatening PH treated with a combined specific vasomodulatory therapy is reported. Sustained clinical and hemodynamic improvement was achieved.
CONCLUSIONS: Further investigation of PH in HP and specific vasomodulatory therapy is necessary.
Details
| Original language | English |
|---|---|
| Pages (from-to) | CS55-7 |
| Journal | Medical science monitor : international medical journal of experimental and clinical research |
| Volume | 16 |
| Issue number | 5 |
| Publication status | Published - May 2010 |
| Peer-reviewed | Yes |
External IDs
| Scopus | 77954251411 |
|---|---|
| PubMed | 20424556 |
| ORCID | /0000-0001-6022-6827/work/142659542 |
Keywords
Keywords
- Alveolitis, Extrinsic Allergic/complications, Chronic Disease, Drug Therapy, Combination, Female, Humans, Hypertension, Pulmonary/complications, Iloprost/administration & dosage, Middle Aged, Phenylpropionates/therapeutic use, Piperazines/administration & dosage, Purines/administration & dosage, Pyridazines/therapeutic use, Sildenafil Citrate, Sulfones/administration & dosage, Vasodilator Agents/therapeutic use